GC32934Relugolix TAK385 10 mg
State & local contract award Virginia Awarded
- Contract number
- A236_P0358433
- Awardee
- GLPBIO TECHNOLOGY INC
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $73.00
About this award
Virginia Commonwealth University (VCU) awarded a contract to GLPBIO Technology Inc. on October 5, 2026, for the delivery of pharmaceutical products. The prime contractor is responsible for supplying Relugolix TAK385 10 mg, a single unit to be delivered to VCU Procurement. The contract carries a cumulative value of $73, with a unit price of $73 per item. The contracting organization, Virginia Commonwealth University, is located in Virginia.
The contract represents a straightforward procurement of a specified pharmaceutical product with a defined delivery location and minimal contract value. No information regarding the period of performance, specific performance location details beyond VCU Procurement, or additional contract terms is provided in the available documentation. The award documentation does not specify annual value or distinct contract amount figures separate from the cumulative value.
Line items
| Item | Total |
|---|---|
| GC32934Relugolix TAK385 10 mg | $73.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0358433?
Contract A236_P0358433 was awarded to GLPBIO TECHNOLOGY INC by Virginia Commonwealth University on October 5, 2026.
How much is contract A236_P0358433 worth?
Its cumulative value is $73.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award